These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Design, synthesis and biological evaluation of 7-(aryl)-2,3-dihydro-[1,4]dioxino[2,3-g]quinoline derivatives as potential Hsp90 inhibitors and anticancer agents. Malayeri SO; Abnous K; Arab A; Akaberi M; Mehri S; Zarghi A; Ghodsi R Bioorg Med Chem; 2017 Feb; 25(3):1294-1302. PubMed ID: 28073608 [TBL] [Abstract][Full Text] [Related]
30. Natural compounds as potential Hsp90 inhibitors for breast cancer-Pharmacophore guided molecular modelling studies. Rampogu S; Parate S; Parameswaran S; Park C; Baek A; Son M; Park Y; Park SJ; Lee KW Comput Biol Chem; 2019 Dec; 83():107113. PubMed ID: 31493740 [TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of 1,3-diphenyl-1H-pyrazole derivatives containing benzimidazole skeleton as potential anticancer and apoptosis inducing agents. Reddy TS; Kulhari H; Reddy VG; Bansal V; Kamal A; Shukla R Eur J Med Chem; 2015 Aug; 101():790-805. PubMed ID: 26231080 [TBL] [Abstract][Full Text] [Related]
32. New heat shock protein (Hsp90) inhibitors, designed by pharmacophore modeling and virtual screening: synthesis, biological evaluation and molecular dynamics studies. Abbasi M; Amanlou M; Aghaei M; Bakherad M; Doosti R; Sadeghi-Aliabadi H J Biomol Struct Dyn; 2020 Aug; 38(12):3462-3473. PubMed ID: 31452440 [TBL] [Abstract][Full Text] [Related]
33. Design, synthesis, and docking studies of quinazoline analogues bearing aryl semicarbazone scaffolds as potent EGFR inhibitors. Tu Y; Wang C; Xu S; Lan Z; Li W; Han J; Zhou Y; Zheng P; Zhu W Bioorg Med Chem; 2017 Jun; 25(12):3148-3157. PubMed ID: 28428040 [TBL] [Abstract][Full Text] [Related]
34. 2,4-Disubstituted quinazolines targeting breast cancer cells via EGFR-PI3K. Li ED; Lin Q; Meng YQ; Zhang LY; Song PP; Li N; Xin JC; Yang P; Bao CN; Zhang DQ; Zhang Y; Wang JK; Zhang QR; Liu HM Eur J Med Chem; 2019 Jun; 172():36-47. PubMed ID: 30939352 [TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers. Mahdy HA; Ibrahim MK; Metwaly AM; Belal A; Mehany ABM; El-Gamal KMA; El-Sharkawy A; Elhendawy MA; Radwan MM; Elsohly MA; Eissa IH Bioorg Chem; 2020 Jan; 94():103422. PubMed ID: 31812261 [TBL] [Abstract][Full Text] [Related]
36. Benzoxazole derivatives as new generation of anti-breast cancer agents. Omar AME; AboulWafa OM; El-Shoukrofy MS; Amr ME Bioorg Chem; 2020 Mar; 96():103593. PubMed ID: 32004897 [TBL] [Abstract][Full Text] [Related]
37. Discovery of 5-aryl-3-thiophen-2-yl-1H-pyrazoles as a new class of Hsp90 inhibitors in hepatocellular carcinoma. Mohamady S; Ismail MI; Mogheith SM; Attia YM; Taylor SD Bioorg Chem; 2020 Jan; 94():103433. PubMed ID: 31785857 [TBL] [Abstract][Full Text] [Related]
38. New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study. Serag MI; Tawfik SS; Badr SMI; Eisa HM Sci Rep; 2024 Mar; 14(1):5474. PubMed ID: 38443456 [TBL] [Abstract][Full Text] [Related]
39. Cytotoxic and Apoptotic Effects of Novel Pyrrolo[2,3-d]Pyrimidine Derivatives Containing Urea Moieties on Cancer Cell Lines. Kilic-Kurt Z; Bakar-Ates F; Karakas B; Kütük Ö Anticancer Agents Med Chem; 2018; 18(9):1303-1312. PubMed ID: 29866023 [TBL] [Abstract][Full Text] [Related]
40. Novel scaffold hopping of potent benzothiazole and isatin analogues linked to 1,2,3-triazole fragment that mimic quinazoline epidermal growth factor receptor inhibitors: Synthesis, antitumor and mechanistic analyses. Rezki N; Almehmadi MA; Ihmaid S; Shehata AM; Omar AM; Ahmed HEA; Aouad MR Bioorg Chem; 2020 Oct; 103():104133. PubMed ID: 32745759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]